Biogen | Der Umsatz

Sales Veränderung Datum
AbbVie USD 12.31B 1.99B 2024-03
Acadia Pharmaceuticals USD 231.04M 19.34M 2023-12
ALKERMES USD 377.48M 3.46M 2023-12
Amgen USD 8.2B 1.29B 2023-12
Bayer EUR 11.86B 1.52B 2023-12
Biogen USD 2.29B 96.3M 2024-03
BioMarin Pharmaceutical USD 649M 2.79M 2024-03
Bristol-Myers Squibb USD 11.9B 423M 2024-03
Eli Lilly USD 9.35B 145.2M 2023-12
Gilead Sciences USD 7.12B 64M 2023-12
Incyte USD 1.01B 94.32M 2023-12
Intra Cellular Therapies USD 132.1M 5.93M 2023-12
Merck USD 15.8B 1.17B 2024-03
Moderna USD 2.81B 980M 2023-12
Neurocrine Biosciences USD 515.2M 16.4M 2023-12
Novartis USD 11.83B 54M 2024-03
Pfizer USD 14.25B 1.02B 2023-12
PTC Therapeutics USD 210.12M 96.94M 2024-03
Regeneron Pharmaceuticals USD 3.43B 71.6M 2023-12
Sanofi EUR 10.92B 1.05B 2023-12
Sanofi EUR 11.75B 1.26B 2023-12
Sarepta Therapeutics USD 396.78M 64.96M 2023-12
Teva Pharmaceutical Industries USD 4.46B 607M 2023-12
Ultragenyx Pharmaceutical USD 127.39M 29.34M 2023-12
United Therapeutics USD 614.7M 5.3M 2023-12
Vertex Pharmaceuticals USD 2.52B 34.2M 2023-12



Biogen Der Umsatz - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Apr 2024.